ID

16096

Description

Safety and Efficacy of Saxagliptin vs.Glimepiride as Add-on Therapy in T2DM Patients With Metformin Monotherapytients; ODM derived from: https://clinicaltrials.gov/show/NCT02280486

Lien

https://clinicaltrials.gov/show/NCT02280486

Mots-clés

Versions (1)
  1. 29/06/2016 29/06/2016 -
Téléchargé le

29 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes NCT02280486

Anglais

Eligibility Type 2 Diabetes NCT02280486

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
for inclusion in the study subjects should fulfill the following criteria:
Description

criteria Following Fulfill

Type de données

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C0332282
UMLS CUI [1,3]
C1550543
provision of informed consent prior to any study specific procedures
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
type2 diabetic patients had been on stable, maximum tolerated doses of metformin (≧1500mg/d, ≧8 weeks)
Description

Diabetes Mellitus, Non-Insulin-Dependent | Metformin Dosage Maximum Stable

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0025598
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0806909
UMLS CUI [2,4]
C0205360
male or female age ≧ 25 years and ≦75 years old
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
hba1c ≧7.0 and ≦9.5%
Description

Hemoglobin A1c measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0474680
bmi ≧ 20 and ≦ 30 kg/m2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects should not enter the study if any of the following exclusion criteria are fulfilled:
Description

Exclusion Criteria Following Fulfill

Type de données

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0332282
UMLS CUI [1,3]
C1550543
known or suspected allergy to trial products or related products.
Description

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Investigational New Drugs Related

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0013230
UMLS CUI [2,4]
C0439849
impaired renal function defined as serum-creatinine ≥ 1.5 mg/dl (≥ 132.6 μmol/l).
Description

Renal Insufficiency | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
acute or chronic disease which may cause tissue hypoxia such as cardiac or respiratory failure, shock.
Description

Disease Causing Tissue hypoxia | Heart failure | Respiratory Failure | Shock

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C4061096
UMLS CUI [2]
C0018801
UMLS CUI [3]
C1145670
UMLS CUI [4]
C0036974
hepatic insufficiency, acute alcohol intoxication, alcoholism.
Description

Hepatic Insufficiency | Acute alcoholic intoxication | Alcoholic Intoxication, Chronic

Type de données

boolean

Alias
UMLS CUI [1]
C1306571
UMLS CUI [2]
C0394996
UMLS CUI [3]
C0001973
subjects has a clinically significant, active (or over the past 12 months) cardiovascular history (including a history of myocardial infarction (mi), arrhythmias or conduction delays on ecg, unstable angina, or decompensated heart failure (new york heart association-class ⅲ and ⅳ).
Description

Cardiovascular Diseases Clinical Significance | Myocardial Infarction | Cardiac Arrhythmia | Electrocardiography Conduction delay | Angina, Unstable | Decompensated cardiac failure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C2826293
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0003811
UMLS CUI [4,1]
C1623258
UMLS CUI [4,2]
C1398354
UMLS CUI [5]
C0002965
UMLS CUI [6]
C0581377
proliferative retinopathy or muscular oedema requiring acute treatment.
Description

Proliferative retinopathy Requirement Therapeutic procedure acute | Muscular edema Requirement Therapeutic procedure acute

Type de données

boolean

Alias
UMLS CUI [1,1]
C0339467
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0087111
UMLS CUI [1,4]
C0205178
UMLS CUI [2,1]
C4021979
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0087111
UMLS CUI [2,4]
C0205178
lactation.
Description

Lactation

Type de données

boolean

Alias
UMLS CUI [1]
C0022925
pregnant or positive pregnancy test at screening, nursing mother, or unwillingness to use adequate contraception (adequate contraceptive measures are sterilization, intrauterine device, oral contraceptives or barrier methods).
Description

Pregnancy | Pregnancy test positive | Breast Feeding | Contraceptive methods Unwilling | Female Sterilization | Intrauterine Devices | Contraceptives, Oral | Contraception, Barrier

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0240802
UMLS CUI [3]
C0006147
UMLS CUI [4,1]
C0700589
UMLS CUI [4,2]
C0558080
UMLS CUI [5]
C0015787
UMLS CUI [6]
C0021900
UMLS CUI [7]
C0009905
UMLS CUI [8]
C0004764
treatment with systemic corticosteroids within the past two months prior to screening.
Description

Therapeutic procedure systemic steroids

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C2825233
tested positive for glutamic acid decarboxylase antibody.
Description

serum glutamic acid decarboxylase (GAD) antibody test Positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C2208796
UMLS CUI [1,2]
C1446409
receipt of any investigational drug within 1 month prior to this trial.
Description

Investigational New Drug Use

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C1524063
Retour au début de la page

Similar models

Eligibility Type 2 Diabetes NCT02280486

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
criteria Following Fulfill
Item
for inclusion in the study subjects should fulfill the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C0332282 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Informed consent
Item
provision of informed consent prior to any study specific procedures
boolean
C0021430 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Metformin Dosage Maximum Stable
Item
type2 diabetic patients had been on stable, maximum tolerated doses of metformin (≧1500mg/d, ≧8 weeks)
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0806909 (UMLS CUI [2,3])
C0205360 (UMLS CUI [2,4])
Age
Item
male or female age ≧ 25 years and ≦75 years old
boolean
C0001779 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c ≧7.0 and ≦9.5%
boolean
C0474680 (UMLS CUI [1])
Body mass index
Item
bmi ≧ 20 and ≦ 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Exclusion Criteria Following Fulfill
Item
subjects should not enter the study if any of the following exclusion criteria are fulfilled:
boolean
C0680251 (UMLS CUI [1,1])
C0332282 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Investigational New Drugs Related
Item
known or suspected allergy to trial products or related products.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
C0439849 (UMLS CUI [2,4])
Renal Insufficiency | Creatinine measurement, serum
Item
impaired renal function defined as serum-creatinine ≥ 1.5 mg/dl (≥ 132.6 μmol/l).
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Disease Causing Tissue hypoxia | Heart failure | Respiratory Failure | Shock
Item
acute or chronic disease which may cause tissue hypoxia such as cardiac or respiratory failure, shock.
boolean
C0012634 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C4061096 (UMLS CUI [1,3])
C0018801 (UMLS CUI [2])
C1145670 (UMLS CUI [3])
C0036974 (UMLS CUI [4])
Hepatic Insufficiency | Acute alcoholic intoxication | Alcoholic Intoxication, Chronic
Item
hepatic insufficiency, acute alcohol intoxication, alcoholism.
boolean
C1306571 (UMLS CUI [1])
C0394996 (UMLS CUI [2])
C0001973 (UMLS CUI [3])
Cardiovascular Diseases Clinical Significance | Myocardial Infarction | Cardiac Arrhythmia | Electrocardiography Conduction delay | Angina, Unstable | Decompensated cardiac failure
Item
subjects has a clinically significant, active (or over the past 12 months) cardiovascular history (including a history of myocardial infarction (mi), arrhythmias or conduction delays on ecg, unstable angina, or decompensated heart failure (new york heart association-class ⅲ and ⅳ).
boolean
C0007222 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0027051 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
C1623258 (UMLS CUI [4,1])
C1398354 (UMLS CUI [4,2])
C0002965 (UMLS CUI [5])
C0581377 (UMLS CUI [6])
Proliferative retinopathy Requirement Therapeutic procedure acute | Muscular edema Requirement Therapeutic procedure acute
Item
proliferative retinopathy or muscular oedema requiring acute treatment.
boolean
C0339467 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0205178 (UMLS CUI [1,4])
C4021979 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C0205178 (UMLS CUI [2,4])
Lactation
Item
lactation.
boolean
C0022925 (UMLS CUI [1])
Pregnancy | Pregnancy test positive | Breast Feeding | Contraceptive methods Unwilling | Female Sterilization | Intrauterine Devices | Contraceptives, Oral | Contraception, Barrier
Item
pregnant or positive pregnancy test at screening, nursing mother, or unwillingness to use adequate contraception (adequate contraceptive measures are sterilization, intrauterine device, oral contraceptives or barrier methods).
boolean
C0032961 (UMLS CUI [1])
C0240802 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0558080 (UMLS CUI [4,2])
C0015787 (UMLS CUI [5])
C0021900 (UMLS CUI [6])
C0009905 (UMLS CUI [7])
C0004764 (UMLS CUI [8])
Therapeutic procedure systemic steroids
Item
treatment with systemic corticosteroids within the past two months prior to screening.
boolean
C0087111 (UMLS CUI [1,1])
C2825233 (UMLS CUI [1,2])
serum glutamic acid decarboxylase (GAD) antibody test Positive
Item
tested positive for glutamic acid decarboxylase antibody.
boolean
C2208796 (UMLS CUI [1,1])
C1446409 (UMLS CUI [1,2])
Investigational New Drug Use
Item
receipt of any investigational drug within 1 month prior to this trial.
boolean
C0013230 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial